- Home
- APGE vs SXI Comparison
APGE vs SXI Comparison
Compare APGE & SXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APGE
- SXI
- Stock Information
- Founded
- APGE 2022
- SXI 1955
- Country
- APGE United States
- SXI United States
- Employees
- APGE N/A
- SXI N/A
- Industry
- APGE Biotechnology: Biological Products (No Diagnostic Substances)
- SXI Industrial Machinery/Components
- Sector
- APGE Health Care
- SXI Industrials
- Exchange
- APGE Nasdaq
- SXI Nasdaq
- Market Cap
- APGE 3.0B
- SXI 2.5B
- IPO Year
- APGE 2023
- SXI N/A
- Fundamental
- Price
- APGE $48.46
- SXI $202.07
- Analyst Decision
- APGE Strong Buy
- SXI Strong Buy
- Analyst Count
- APGE 6
- SXI 3
- Target Price
- APGE $75.40
- SXI $227.00
- AVG Volume (30 Days)
- APGE 588.6K
- SXI 41.6K
- Earning Date
- APGE 11-12-2024
- SXI 01-30-2025
- Dividend Yield
- APGE N/A
- SXI 0.64%
- EPS Growth
- APGE N/A
- SXI N/A
- EPS
- APGE N/A
- SXI 6.09
- Revenue
- APGE N/A
- SXI $706,325,000.00
- Revenue This Year
- APGE N/A
- SXI $12.37
- Revenue Next Year
- APGE N/A
- SXI $9.27
- P/E Ratio
- APGE N/A
- SXI $32.89
- Revenue Growth
- APGE N/A
- SXI N/A
- 52 Week Low
- APGE $22.20
- SXI $140.04
- 52 Week High
- APGE $72.29
- SXI $212.66
- Technical
- Relative Strength Index (RSI)
- APGE 47.85
- SXI 47.87
- Support Level
- APGE $41.85
- SXI $198.40
- Resistance Level
- APGE $48.27
- SXI $212.65
- Average True Range (ATR)
- APGE 3.56
- SXI 3.95
- MACD
- APGE 0.31
- SXI -1.56
- Stochastic Oscillator
- APGE 47.51
- SXI 19.09
About APGE Apogee Therapeutics Inc.
Apogee Therapeutics Inc is a biotechnology company seeking to develop differentiated biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications with high unmet need. Its antibody programs are designed to overcome the limitations of existing therapies by targeting well-established mechanisms of action and incorporating advanced antibody engineering to optimize half-life and other properties. Its two programs are APG777 and APG808, which initially develop for treating AD and COPD, respectively.
About SXI Standex International Corporation
Standex International Corp is an industrial manufacturer of different products and services used in commercial and industrial markets. It has five reportable segments; Electronics; Engraving; Scientific; Engineering Technologies and Specialty Solutions. The maximum revenue is generated from its Electronics segment which is a component and value-added services provider of both sensing and switching technologies as well as magnetic power conversion components and assemblies, like custom wound transformers and inductors, current sense technology, value-added assemblies, and mechanical packaging among others. Geographically, it derives key revenue from the United States and the rest from Asia Pacific, Europe, Middle East and South Africa (EMEA), and other regions.